| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/23/2007 | US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
| 01/23/2007 | US7166296 Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1 |
| 01/23/2007 | US7166270 Exposing eukaryotic organisms to a single fungal pathogen in the presence of at least one candidate compound; identifying a compound that inhibits fungal pathogen in each of eukaryotic organisms |
| 01/23/2007 | CA2173841C Ultrasonic spectral contrast imaging |
| 01/23/2007 | CA2107400C Method of grinding pharmaceutical substances |
| 01/18/2007 | WO2007008824A2 Minimally invasive allergy testing system |
| 01/18/2007 | WO2007008080A2 Optical imaging contrast agents |
| 01/18/2007 | WO2006014381A3 Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies |
| 01/18/2007 | WO2005079384A3 Expandable gastric retention device |
| 01/18/2007 | WO2005042695A3 Lipoparticles comprising proteins, methods of making, and using the same |
| 01/18/2007 | US20070016075 Agent for detecting sentinel lymph node and detection method |
| 01/18/2007 | US20070014731 Vesicles comprising a flexible non-proteinaceous amphiphilic polymer capable of forming gas-containing vesicles; enhanced echocardiographic imaging |
| 01/18/2007 | US20070014730 Compositions containing magnetic iron oxide particles, and use of said compositions in imaging methods |
| 01/18/2007 | US20070014728 Device and method for increasing the throughput of irritation testing of transdermal formulations |
| 01/18/2007 | US20070014726 Oxidation-resistant indicator macromolecule |
| 01/18/2007 | US20070014725 Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy |
| 01/18/2007 | US20070014719 Steroid analogs and characterization and treatment methods |
| 01/18/2007 | US20070014718 Kits for gastric emptying measurement |
| 01/18/2007 | DE102005033903A1 New perfluoroalkyl-containing metal complexes, useful for production of contrast agents for use in e.g. NMR and X-ray diagnostics, necrosis imaging and in radiodiagnostics and radiotherapy |
| 01/18/2007 | DE102004035803B4 Verfahren zur Herstellung von in Wasser dispergierten Eisenoxid-Nanoteilchen und deren Anwendung A process for preparing water-dispersed iron oxide nanoparticles and their use |
| 01/18/2007 | CA2613619A1 Sp1 polypeptides, modified sp1 polypeptides and uses thereof |
| 01/17/2007 | EP1743941A1 Novel mite allergen |
| 01/17/2007 | EP1743658A1 Optical imaging of rheumatoid arthritis |
| 01/17/2007 | EP1743521A1 Method of constructing animal model suffering from left ventricular diastolic disorder for examining heart failure and method of examining remedy for heart failure caused by left ventricular diastolic failure with the use of the animal model |
| 01/17/2007 | EP1743174A2 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 01/17/2007 | EP1742926A1 Macrocycle-substituted trimer halogen-benzol derivatives |
| 01/17/2007 | EP1742669A1 Compositions and methods for enhancing contrast in imaging |
| 01/17/2007 | EP1335646B1 Transgenic or recombinant non-human mammals for stop protein and their uses in screening psycho-active medicines |
| 01/17/2007 | EP1272160B1 Lipid-based drug delivery systems for topical application |
| 01/17/2007 | CN1898378A Stem cell targeting using magnetic particles |
| 01/17/2007 | CN1897979A Gas-filled microvesicle assembly for contrast imaging |
| 01/17/2007 | CN1897978A Assembly of gas-filled microvesicle with active component for contrast imaging |
| 01/17/2007 | CN1895678A Microvesicle ultrasonic biologically-degradable contrast medium containing polymer and its preparation |
| 01/17/2007 | CN1895677A Paramagnetic metal coordination compound magnetic resonance imaging contrast medium with narrow-leaved oleaster polyose modification |
| 01/17/2007 | CN1895160A Biological simulation system and computer program product |
| 01/16/2007 | US7164016 Complex containing radioactive material; medical diagnosis of tumor |
| 01/16/2007 | US7163935 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163798 Method of preparing cow brain homogenate |
| 01/16/2007 | US7163397 Apparatus for applying material for selectively modifying the optical properties of metabolically different cells |
| 01/16/2007 | CA2168963C Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases |
| 01/16/2007 | CA2069759C Liposomes as contrast agents for ultrasonic imaging |
| 01/11/2007 | WO2007006041A2 Imaging and therapeutic method using monocytes |
| 01/11/2007 | WO2007005491A1 Hydrazide conjugates as imaging agents |
| 01/11/2007 | WO2007005283A2 Use of dtbz for imaging endocrine pancreas and beta cell mass in type 1 diabetes |
| 01/11/2007 | WO2007004873A1 Device and method for determining the concentration of a substance |
| 01/11/2007 | WO2007004484A1 Pva particle for use in temporary embolization of blood vessel, process for production thereof, and temporary embolizing agent for blood vessel |
| 01/11/2007 | WO2007003944A2 Compounds for imaging and therapy |
| 01/11/2007 | WO2006123937A3 Contrast agents |
| 01/11/2007 | WO2006110172A3 Steroid analogs and characterization and treatment methods |
| 01/11/2007 | WO2006008179A3 Cyanine dyes conjugated with antibodies for the diagnosis of micrometastasis |
| 01/11/2007 | US20070010577 Administering an emulsion of a nanoparticulate carrier containing an alpha v beta 3 integrin targeting ligand and fumagillin, TNP 470 or rapamycin that are coupled through colocalization in the nanoparticles; the antiangiogenic agent is effective at a dosage at least 56,000 fold lower than the free drug |
| 01/11/2007 | US20070010575 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/11/2007 | US20070010476 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/11/2007 | US20070009442 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules |
| 01/11/2007 | US20070009441 Biodegradable nanoparticles |
| 01/11/2007 | US20070009440 Peptide Conjugates and Fluorescence Detection Methods for Intarcellular Caspase Assay |
| 01/11/2007 | US20070009439 Diabetogenic rat model |
| 01/11/2007 | US20070009438 Method for diagnosing diabetes type 2 using standardized mixed meal and calculated index values |
| 01/11/2007 | US20070009434 Imaging and therapeutic method using monocytes |
| 01/11/2007 | US20070009431 Solution and method for supporting imaging on a patient |
| 01/11/2007 | DE60210297T2 Verwendung von langem pentraxin ptx3 für die behandlung von infertilität bei frauen Use of long pentraxin PTX3 for the treatment of infertility in women |
| 01/11/2007 | DE19713456B4 Verfahren zur Herstellung einer für die Synthese von iodierten Kontrastmitteln nützlichen Zwischenverbindung A process for producing a useful for the synthesis of iodinated contrast agents intercommunication |
| 01/11/2007 | DE10225932B4 Bildgebendes Verfahren und Vorrichtung zu dessen Durchführung Imaging method and device for its implementation |
| 01/11/2007 | DE102005031755A1 New peptides that bind to Salmonella, useful for immobilization, detection, concentration and labeling, optionally derivatized with a pharmaceutical |
| 01/11/2007 | CA2848662A1 Il-12/p40 binding proteins |
| 01/11/2007 | CA2623794A1 Use of dtbz for imaging endocrine pancreas and beta cell mass in type 1 diabetes |
| 01/11/2007 | CA2613439A1 Hydrazide conjugates as imaging agents |
| 01/10/2007 | EP1742038A1 Device and method for determining the concentration of a substance |
| 01/10/2007 | EP1741450A1 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 01/10/2007 | EP1741334A2 Method for producing diabetic rat with high fat diet |
| 01/10/2007 | EP1740611A2 Ion channel |
| 01/10/2007 | EP1740225A2 Contrast agents for myocardial perfusion imaging |
| 01/10/2007 | EP1740223A1 Method for characterizing the oxidative stress protective capacity of an antioxidative substance |
| 01/10/2007 | EP1740222A1 Biological assay |
| 01/10/2007 | EP1740187A1 Macular edema patient selection method and treatment with eye implant comprising a steroid |
| 01/10/2007 | EP1658294B1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 01/10/2007 | EP1206288B1 Targeted fiberless radiative effectors |
| 01/10/2007 | EP1153029B1 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents |
| 01/10/2007 | CN1894344A Compounds for dual photodiagnosis and therapy |
| 01/10/2007 | CN1894212A Near-infrared fluorescent contrast medium |
| 01/10/2007 | CN1893982A Menthol-containing preparation |
| 01/10/2007 | CN1893976A Radiation therapy and medical imaging using uv emitting nanoparticles |
| 01/10/2007 | CN1891178A Model for immunocomparability |
| 01/10/2007 | CN1293920C Process for preparing active target-directional carrier mediated by folic acid compound mediated |
| 01/09/2007 | US7161059 infecting a non-human primate with a non-adapted or non-passaged human hookworm and maintaining the non-human primate; use as a vaccine; a model for maintaining and investigating human hookworm. |
| 01/09/2007 | US7160734 Retentate chromatography and protein chip arrays with applications in biology |
| 01/09/2007 | US7160698 Transformed plant or fish cells with the isolated polynucleotide; wider array of colors and biochemical features compared to existing wild-type green fluorescent protein |
| 01/09/2007 | US7160676 Exposing the test sperm to the a stimuli; fixing this sperm in a fixative of paraformaldehyde, glutaraldehyde or mixtures; staining the fixed sperm to determine the GM1 (monosialotetrahexosylganglioside) distribution pattern; comparing with a stained normal sperm sample having undergone the same testing |
| 01/09/2007 | CA2308520C Strictly alternating poly(alkylene oxide ether) copolymers |
| 01/09/2007 | CA2286190C Gnrh antagonists being modified in positions 5 and 6 |
| 01/09/2007 | CA2270391C Ex-corpore method for treating human blood cells |
| 01/09/2007 | CA2246842C Reagent for evaluating a hepatic operation |
| 01/09/2007 | CA2201620C Diagnostic and diagnosis method for central nervous abnormality and phenylketonuria |
| 01/04/2007 | WO2007002482A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 01/04/2007 | WO2007002109A2 Multidentate pyrone-derived chelators for medicinal imaging and chelation |
| 01/04/2007 | WO2007001406A2 Aryl-containing macrocyclic compounds |
| 01/04/2007 | WO2007000351A1 Compositions containing magnetic iron oxide particles and use of said compositions in magnetic particle imaging |
| 01/04/2007 | WO2007000350A1 Compositions containing magnetic iron oxide particles, and use of said compositions in magnetic particle imaging |
| 01/04/2007 | WO2007000349A2 Optical imaging of rheumatoid arthritis |